SOSTOS LLC
Medtech · Private
qRT-PCR-based microfluidic 7-gene assay (CATOS-LU) that predicts lung cancer recurrence risk in early-stage NSCLC patients
- Grants
- $2.2M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: A web portal for artificial intelligence (AI)-based comprehensive discovery of repositioning drugs | $295,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Accurate prognosis and prediction of clinical benefits of adjuvant therapy for early-stage non-small cell lung cancer | $400,000 | |
| Federal grant· 1 of 2 same day | National Science Foundation · Phase II · SBIR Phase II: An advanced web portal for artificial intelligence (AI)-based comprehensive discovery of repositioning drugs | $1,236,522 | |
| Federal grant· 2 of 2 same day | National Science Foundation · Phase I · SBIR Phase I: AI-Enabled Discovery of Multi-Omics Biomarkers Applicable to Broad Cancer Populations | $305,000 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1449 | Oxford Biodynamics PLC | — | $5.0M |
| 1450 | EUTROPICS PHARMACEUTICALS, INC. | — | $350K |
| 1451 | CELLOGY, INC. | — | — |
| 1452 | SOSTOS LLC | — | — |
| 1453 | Cradle Genomics, Inc. | — | — |
| 1454 | DELPOR INC | — | $1.4M |
| 1455 | Daedalus Medical Solutions, Inc. | — | $380K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.